1088026

Neopharm Labs Inc. — FEI 3002807703

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Blainville (Canada)